| LRSRX | SSGSX | LRSRX / SSGSX | |
| Total Expense Ratio | 1.46 | 1.26 | 116% |
| Annual Report Gross Expense Ratio | 1.46 | 1.26 | 116% |
| Fund Existence | 18 years | 27 years | - |
| Gain YTD | -6.177 | -4.415 | 140% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 347M | 4.98B | 7% |
| Annual Yield % from dividends | 0.00 | 0.49 | - |
| Returns for 1 year | -19.31 | -14.44 | 134% |
| Returns for 3 years | 6.78 | -10.47 | -65% |
| Returns for 5 years | 0.70 | 2.06 | 34% |
| Returns for 10 years | -50.64 | 12.64 | -401% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSTSX | 19.57 | N/A | N/A |
| Fidelity Series International Sm Cap | |||
| TGRFX | 6.91 | N/A | N/A |
| Transamerica International Focus R6 | |||
| RAFEX | 45.74 | -0.38 | -0.82% |
| American Funds AMCAP R4 | |||
| LZIOX | 20.11 | -0.26 | -1.28% |
| Lazard International Equity Open | |||
| MCYAX | 13.45 | -0.19 | -1.39% |
| NYLI Candriam Emerging Markets Eq Cl A | |||